Skip to Main Content

Author Details

William Robert Lee
Duke University School of Medicine
1993
232
50
PMIDPaper TitleJournal TitlePublished Year
36849728Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415.Prostate Cancer Prostatic Dis2024
36203051Second generation anti-androgens and androgen deprivation therapy with radiation therapy in the definitive management of high-risk prostate cancer.Prostate Cancer Prostatic Dis2023
37391236The Radiation Oncology Match in 2023: Suggestion of a Nadir.Pract Radiat Oncol2023
37408675Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement.Adv Radiat Oncol2023
36579471The importance of body composition in patients with prostate cancer receiving radiotherapy.Cancer2023
36736921Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415.Int J Radiat Oncol Biol Phys2023
36426110Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting.Fed Pract2022
35675855The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521.Int J Radiat Oncol Biol Phys2022
35717051Unfilled Positions in the 2022 Radiation Oncology Match: A Reduction in Positions.Pract Radiat Oncol2022
35776901Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415.JCO Clin Cancer Inform2022
33036061Reconciling outcomes for Black men with prostate cancer within and outside the Veterans Health Administration.Cancer2021
35387417Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer.Adv Radiat Oncol2021
33852571Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415.PLoS One2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
34742458Facilitating the Transition to Independent Radiation Oncology Practice Through a Resident-Led, Veterans Affairs Teaching Hospital Service.Pract Radiat Oncol2021
33975051Unfilled Positions in the 2021 Radiation Oncology Match.Pract Radiat Oncol2021
32063492Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.Eur Urol Oncol2021
33275486Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis.J Clin Oncol2021
33361287Early salvage versus adjuvant therapy for treatment of prostate cancer following prostatectomy.BMJ Evid Based Med2021
33390241Gratitude Is the Attitude: Acknowledgments After 10 Years With Practical Radiation Oncology.Pract Radiat Oncol2021
33259932Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2021
32139334Grateful Recognition of PRO Reviewer Apprentices and Reviewers of the Year.Pract Radiat Oncol2020
32107176Practical Radiation Oncology's Top 20 Downloads of 2019.Pract Radiat Oncol2020
32422396Unfilled Positions in the 2020 Radiation Oncology Residency Match: No Longer an Isolated Event.Pract Radiat Oncol2020
32215583Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.JAMA Oncol2020
32143832Editor's Note.Pract Radiat Oncol2020
32238327What Can Journals Do to Increase the Reliability of Scientific Research?Pract Radiat Oncol2020
30419308A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate Cancer.Int J Radiat Oncol Biol Phys2019
31673648ASTRO Journals' Data Sharing Policy and Recommended Best Practices.Adv Radiat Oncol2019
31503326Proton-beam therapy after radical prostatectomy: Continued DVH idolatry?Cancer2019
31563531Radiation Biology for Radiation Oncology Residents: An Alternative View.Pract Radiat Oncol2019
31100471The High Number of Unfilled Positions in the 2019 Radiation Oncology Residency Match: Temporary Variation or Indicator of Important Change?Pract Radiat Oncol2019
31015166Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.Radiother Oncol2019
30797697Comments on: High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localize prostate cancer: toxicity and 6-years biochemical results.Brachytherapy2019
30967225A Call for Change in the ABR Initial Certification Examination in Radiation Oncology.Int J Radiat Oncol Biol Phys2019
29128208Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.Eur Urol2018
30050793Moderate hypofractionation for prostate cancer.Transl Androl Urol2018
29980386Thoughts on the American Board of Radiology Examinations and the resident experience in radiation oncology.Pract Radiat Oncol2018
29976488Scholarly Publishing and the Metric System.Int J Radiat Oncol Biol Phys2018
30706027Nonuniform Planning Target Volume Margins for Prostate Bed on the Basis of Surgical Clips on Daily Cone Beam Computed Tomography.Adv Radiat Oncol2018
30316827Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.Lancet Oncol2018
29353655Cost-Effectiveness of Primary Radiation Therapy Versus Radical Prostatectomy for Intermediate- to High-Risk Prostate Cancer.Int J Radiat Oncol Biol Phys2018
29372236Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.JAMA Oncol2018
29559284Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens.Int J Radiat Oncol Biol Phys2018
28244406Six Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer.Int J Radiat Oncol Biol Phys2017
28463167Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.Int J Radiat Oncol Biol Phys2017
28439366Why the Aversion?J Grad Med Educ2017
28086825Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer.Radiat Oncol2017
26754260A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.Prostate Cancer Prostatic Dis2016
28078230Invited commentary on GETUG-AFU 16.Transl Androl Urol2016
  • 1 - 50 of 232

Recommended Authors

Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 4
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 44
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 12
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 3
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 5
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year 2005
Number of shared co-authors 30
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 3
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 42
Albert J Chang
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 35
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 27
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 36
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 5
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 29
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 33
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 6
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 13
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 21
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 7
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 21
Almudena Zapatero
University Hospital La Princesa
Career Start Year 1995
Number of shared co-authors 33
Jay P Ciezki
Cleveland Clinic
Career Start Year 1995
Number of shared co-authors 32
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 6
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 33
Richard Choo
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 27
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 43
David Joseph
Sir Charles Gairdner Hospital
Career Start Year 1990
Number of shared co-authors 34
Christopher R King
University of California los angeles
Career Start Year 1988
Number of shared co-authors 29
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 24
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 9
James W Denham
University of Newcastle
Career Start Year 1980
Number of shared co-authors 34

Collaborators

Bridget F Koontz
Duke University School of Medicine
Co-authored papers 22
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 22
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 21
Thomas M Pisansky
Mayo Clinic
Co-authored papers 19
Alexandra L Hanlon
Virginia Tech
Co-authored papers 19
Mack Roach
University of California San Francisco
Co-authored papers 16
Alan Pollack
University of Miami Miller School of Medicine
Co-authored papers 14
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 9
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Co-authored papers 9
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Co-authored papers 9
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 5
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 5
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 5
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 5
Drew Moghanaki
University of California Los Angeles
Co-authored papers 4
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 4
Stephanie L Pugh
Co-authored papers 3
Gregory S Merrick
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 3
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 3
Anthony V D'Amico
Duke University Medical Center
Co-authored papers 3
Oliver Sartor
Tulane University School of Medicine
Co-authored papers 3
Devon J Godfrey
Duke University Medical Center
Co-authored papers 3
Robert T Dess
University of Michigan ann arbor
Co-authored papers 3
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 3
Amar U Kishan
University of California los angeles
Co-authored papers 3
William C Jackson
University of Michigan ann arbor
Co-authored papers 3
Mark K Buyyounouski
Stanford University
Co-authored papers 2
Cheryl Crozier
Ontario Institute for Cancer Research
Co-authored papers 2
Holly E Hartman
Case Western Reserve University
Co-authored papers 2
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 2
Release 1.2